Neogen EBITDA Margin 2010-2024 | NEOG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Neogen (NEOG) over the last 10 years. The current EBITDA margin for Neogen as of May 31, 2024 is .
| Neogen EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-05-31 | $0.93B | $0.18B | 19.89% |
| 2024-02-29 | $0.93B | $0.19B | 20.65% |
| 2023-11-30 | $0.92B | $0.19B | 21.00% |
| 2023-08-31 | $0.92B | $0.17B | 18.28% |
| 2023-05-31 | $0.82B | $0.13B | 15.94% |
| 2023-02-28 | $0.72B | $0.10B | 13.89% |
| 2022-11-30 | $0.63B | $0.07B | 10.95% |
| 2022-08-31 | $0.53B | $0.07B | 12.62% |
| 2022-05-31 | $0.53B | $0.08B | 15.56% |
| 2022-02-28 | $0.51B | $0.08B | 16.34% |
| 2021-11-30 | $0.50B | $0.09B | 18.29% |
| 2021-08-31 | $0.49B | $0.10B | 20.12% |
| 2021-05-31 | $0.47B | $0.10B | 20.30% |
| 2021-02-28 | $0.45B | $0.09B | 20.89% |
| 2020-11-30 | $0.43B | $0.09B | 21.02% |
| 2020-08-31 | $0.43B | $0.09B | 21.13% |
| 2020-05-31 | $0.42B | $0.09B | 20.81% |
| 2020-02-29 | $0.42B | $0.09B | 20.29% |
| 2019-11-30 | $0.42B | $0.09B | 20.62% |
| 2019-08-31 | $0.42B | $0.09B | 20.67% |
| 2019-05-31 | $0.42B | $0.09B | 20.72% |
| 2019-02-28 | $0.41B | $0.09B | 21.07% |
| 2018-11-30 | $0.41B | $0.09B | 21.46% |
| 2018-08-31 | $0.40B | $0.09B | 21.53% |
| 2018-05-31 | $0.40B | $0.09B | 21.61% |
| 2018-02-28 | $0.39B | $0.09B | 22.02% |
| 2017-11-30 | $0.38B | $0.08B | 21.90% |
| 2017-08-31 | $0.37B | $0.08B | 21.95% |
| 2017-05-31 | $0.36B | $0.08B | 22.01% |
| 2017-02-28 | $0.35B | $0.08B | 21.25% |
| 2016-11-30 | $0.34B | $0.07B | 20.76% |
| 2016-08-31 | $0.33B | $0.07B | 20.85% |
| 2016-05-31 | $0.32B | $0.07B | 21.43% |
| 2016-02-29 | $0.31B | $0.07B | 21.54% |
| 2015-11-30 | $0.30B | $0.07B | 22.52% |
| 2015-08-31 | $0.29B | $0.07B | 22.76% |
| 2015-05-31 | $0.28B | $0.06B | 22.61% |
| 2015-02-28 | $0.27B | $0.06B | 22.51% |
| 2014-11-30 | $0.27B | $0.06B | 22.26% |
| 2014-08-31 | $0.26B | $0.06B | 21.40% |
| 2014-05-31 | $0.25B | $0.05B | 21.37% |
| 2014-02-28 | $0.24B | $0.05B | 21.52% |
| 2013-11-30 | $0.23B | $0.05B | 22.12% |
| 2013-08-31 | $0.22B | $0.05B | 23.04% |
| 2013-05-31 | $0.21B | $0.05B | 23.08% |
| 2013-02-28 | $0.20B | $0.05B | 22.89% |
| 2012-11-30 | $0.20B | $0.04B | 22.05% |
| 2012-08-31 | $0.19B | $0.04B | 21.69% |
| 2012-05-31 | $0.19B | $0.04B | 21.62% |
| 2012-02-29 | $0.18B | $0.04B | 22.22% |
| 2011-11-30 | $0.18B | $0.04B | 22.60% |
| 2011-08-31 | $0.18B | $0.04B | 23.30% |
| 2011-05-31 | $0.17B | $0.04B | 23.70% |
| 2011-02-28 | $0.17B | $0.04B | 23.21% |
| 2010-11-30 | $0.16B | $0.04B | 23.13% |
| 2010-08-31 | $0.15B | $0.03B | 22.52% |
| 2010-05-31 | $0.14B | $0.03B | 22.14% |
| 2010-02-28 | $0.13B | $0.03B | 21.97% |
| 2009-11-30 | $0.13B | $0.03B | 21.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.799B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |